María Carmen Navarro Navarro-rekin lankidetzan egindako argitalpenak (31)

2021

  1. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2018

  1. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years

    Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301

  2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

2017

  1. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  2. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  3. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  4. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 301-316

  5. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  6. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  7. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

2012

  1. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe

    European Journal of Surgical Oncology, Vol. 38, Núm. 3, pp. 214-221

2010

  1. Population-based cancer registries in Spain and their role in cancer control

    Annals of Oncology, Vol. 21, Núm. SUPPL.3

2009

  1. Comparative cancer survival information in Europe

    European Journal of Cancer

  2. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 931-991

  3. Long-term survival expectations of cancer patients in Europe in 2000-2002

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1028-1041

  4. Survival of European children and young adults with cancer diagnosed 1995-2002

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 992-1005

  5. Survival trends in European cancer patients diagnosed from 1988 to 1999

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1042-1066

  6. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 909-930

  7. The advantage of women in cancer survival: An analysis of EUROCARE-4 data

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1017-1027